Clinical Trials
2 trialsNCT06951646 2026-03-09
ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive)
Second Xiangya Hospital of Central South University
Phase 2 Recruiting
NCT00551577 2007-10-31
PRIMOVAR-1
University Hospital, Bonn
Phase 2 Unknown